Leucovorin Pharmacenter

Folinic acid, the active ingredient in Leucovorin Pharmacenter, is a folate analog presented as an injectable solution for intramuscular and intravenous use. It is employed as an antineoplastic adjuvant to mitigate methotrexate toxicity and to enhance the efficacy of 5‑fluorouracil in cancer patients.

GNH USA supplies Leucovorin Pharmacenter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Leucovorin (folinic acid) is employed in oncology to support folate‑dependent pathways during chemotherapy.

- Methotrexate toxicity: provides rescue therapy that reduces toxic effects of high‑dose methotrexate. - Colorectal and other solid tumours receiving 5‑fluorouracil: enhances chemotherapeutic efficacy. - High‑dose methotrexate regimens: used as leucovorin rescue after treatment to protect normal cells.

Leucovorin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Vomiting: occasional emesis after infusion. - Rash: transient skin erythema or itching. - Flushing: brief warmth or redness. - Headache: mild to moderate intensity. - Mild fever: low‑grade temperature elevation.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Severe hypotension: sudden drop in blood pressure during infusion. - Acute renal dysfunction: impaired kidney function observed in rare cases. - Stevens‑Johnson syndrome: severe skin and mucosal reaction. - Thrombocytopenia: notable drop in platelet count.

Leucovorin should be used with careful clinical oversight.

- Renal function: assess before administration and monitor during therapy. - Pregnancy: risk category unknown; avoid unless clearly indicated. - Breastfeeding: discontinue if adverse effects observed in infant. - Hypersensitivity: discontinue immediately if signs of allergic reaction appear. - Concomitant methotrexate: ensure appropriate rescue timing to avoid toxicity. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Leucovorin may interact with several agents; monitoring is essential.

Major Interactions (Avoid): - Methotrexate: antagonizes methotrexate effect if not timed correctly. - Other antifolates (e.g., pemetrexed): may reduce therapeutic efficacy.

Moderate Interactions (Monitor Closely): - Nephrotoxic drugs (e.g., aminoglycosides): monitor renal function. - Cytotoxic agents (e.g., cisplatin): adjust dosing as needed. - Electrolyte disturbances: correct imbalances before infusion.